Salvadori Daniel Gesua Sive

CIK 00016205641 companyABBOTT PARK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001620564

Recent Transactions

50 trades

Gift
ABBOTT LABORATORIES$ABT
Common shares without par value
2025-12-11$123.28/sh−1,536→ 132,233 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2025-02-28$135.87/sh−8,462→ 133,769 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2025-02-25+61,580→ 61,580 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2025-02-25+16,534→ 142,231 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2025-01-30$128.50/sh−23,771→ 125,697 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2025-01-30−23,771→ 0 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2025-01-30$38.40/sh+23,771→ 149,468 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2024-03-01$118.50/sh−963→ 125,697 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2024-02-29$120.05/sh−8,874→ 126,660 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2024-02-21+58,898→ 58,898 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2024-02-21+15,673→ 135,534 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2023-03-01$100.70/sh−1,085→ 119,861 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2023-02-28$99.77/sh−9,002→ 120,946 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2023-02-17+69,803→ 69,803 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2023-02-17+17,700→ 129,948 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2022-03-01$118.17/sh−1,550→ 112,248 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2022-02-28$122.41/sh−10,551→ 113,798 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2022-02-18+111,474→ 111,474 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2022-02-18+23,919→ 124,349 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2021-12-23−31,229→ 75,591 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-23$140.00/sh−58,501→ 100,430 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-23$44.40/sh+31,229→ 158,931 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-23$38.40/sh+23,771→ 127,702 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2021-12-23−23,771→ 23,771 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-13$44.40/sh+31,229→ 158,931 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2021-12-13−23,771→ 47,542 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-13$135.00/sh−55,000→ 103,931 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-13$38.40/sh+23,771→ 127,702 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-12-13$135.00/sh−3,499→ 103,931 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2021-12-13−31,229→ 60,803 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-03-01$120.61/sh−1,664→ 107,430 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-02-26$121.58/sh−12,596→ 109,094 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2021-02-19+19,257→ 121,690 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2021-02-19+98,708→ 98,708 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-08-27$111.86/sh−42,479→ 102,433 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2020-08-27−42,479→ 0 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-08-27$47.00/sh+42,479→ 144,912 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-07-21$99.08/sh−1,060→ 102,433 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-03-02$77.89/sh−999→ 103,493 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-02-28$79.19/sh−12,279→ 104,492 total
Award
ABBOTT LABORATORIES$ABT
Options (right to buy)
2020-02-21+132,182→ 132,182 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-02-21+21,683→ 116,771 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-07-21$87.49/sh−1,060→ 95,088 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-06-26$38.40/sh+71,000→ 167,148 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-06-26$84.00/sh−71,000→ 96,148 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-06-26−71,000→ 71,313 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-06-13$82.00/sh−3,331→ 96,148 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-06-11$82.00/sh−7,269→ 99,479 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.00/sh−1,664→ 106,748 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-02-28$77.23/sh−11,097→ 108,412 total

Companies

ABBOTT LABORATORIES
Senior Vice President
$ABT

Recent Filings

Address

100 ABBOTT PARK ROAD

ABBOTT PARK, IL, 60064

View on SEC.gov